BRAINSWAY LTD-ADR (BWAY) Stock Fundamental Analysis
USA - NASDAQ:BWAY - US10501L1061 - ADR
16 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to BWAY. BWAY was compared to 190 industry peers in the Health Care Equipment & Supplies industry. While BWAY has a great health rating, its profitability is only average at the moment. BWAY is evaluated to be cheap and growing strongly. This does not happen too often! With these ratings, BWAY could be worth investigating further for value and growth investing!.
1. Profitability
1.1 Basic Checks
BWAY had positive earnings in the past year.
BWAY had a positive operating cash flow in the past year.
In the past 5 years BWAY reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: BWAY reported negative operating cash flow in multiple years.
1.2 Ratios
BWAY has a better Return On Assets (4.79%) than 81.68% of its industry peers.
BWAY's Return On Equity of 7.84% is amongst the best of the industry. BWAY outperforms 81.68% of its industry peers.
BWAY has a better Return On Invested Capital (1.83%) than 69.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.79% | ||
| ROE | 7.84% | ||
| ROIC | 1.83% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BWAY has a better Profit Margin (11.60%) than 86.91% of its industry peers.
BWAY has a better Operating Margin (4.05%) than 68.59% of its industry peers.
BWAY has a better Gross Margin (74.52%) than 86.39% of its industry peers.
In the last couple of years the Gross Margin of BWAY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.05% | ||
| PM (TTM) | 11.6% | ||
| GM | 74.52% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
2. Health
2.1 Basic Checks
BWAY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BWAY has more shares outstanding
Compared to 5 years ago, BWAY has more shares outstanding
Compared to 1 year ago, BWAY has a worse debt to assets ratio.
2.2 Solvency
BWAY has an Altman-Z score of 4.25. This indicates that BWAY is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BWAY (4.25) is better than 74.87% of its industry peers.
BWAY has a debt to FCF ratio of 0.33. This is a very positive value and a sign of high solvency as it would only need 0.33 years to pay back of all of its debts.
BWAY has a better Debt to FCF ratio (0.33) than 93.19% of its industry peers.
BWAY has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
BWAY has a better Debt to Equity ratio (0.08) than 65.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.33 | ||
| Altman-Z | 4.25 |
ROIC/WACC0.21
WACC8.74%
2.3 Liquidity
A Current Ratio of 3.51 indicates that BWAY has no problem at all paying its short term obligations.
BWAY's Current ratio of 3.51 is fine compared to the rest of the industry. BWAY outperforms 65.44% of its industry peers.
BWAY has a Quick Ratio of 3.34. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
BWAY has a Quick ratio of 3.34. This is in the better half of the industry: BWAY outperforms 69.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.51 | ||
| Quick Ratio | 3.34 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 1178.38% over the past year.
The Revenue has grown by 26.50% in the past year. This is a very strong growth!
BWAY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.17% yearly.
EPS 1Y (TTM)1178.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%141.89%
Revenue 1Y (TTM)26.5%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%21.26%
3.2 Future
BWAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.27% yearly.
BWAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.29% yearly.
EPS Next Y58.83%
EPS Next 2Y54.54%
EPS Next 3Y53.27%
EPS Next 5YN/A
Revenue Next Year15%
Revenue Next 2Y18.5%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 15.84, which indicates a correct valuation of BWAY.
Based on the Price/Earnings ratio, BWAY is valued cheaply inside the industry as 85.86% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.42. BWAY is valued slightly cheaper when compared to this.
BWAY is valuated reasonably with a Price/Forward Earnings ratio of 10.61.
BWAY's Price/Forward Earnings ratio is rather cheap when compared to the industry. BWAY is cheaper than 93.19% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BWAY to the average of the S&P500 Index (22.94), we can say BWAY is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.84 | ||
| Fwd PE | 10.61 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BWAY is valued a bit cheaper than the industry average as 64.40% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, BWAY is valued cheaply inside the industry as 89.53% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.24 | ||
| EV/EBITDA | 58.46 |
4.3 Compensation for Growth
BWAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BWAY's earnings are expected to grow with 53.27% in the coming years.
PEG (NY)0.27
PEG (5Y)N/A
EPS Next 2Y54.54%
EPS Next 3Y53.27%
5. Dividend
5.1 Amount
No dividends for BWAY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:BWAY (10/17/2025, 8:00:02 PM)
16
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners5.13%
Inst Owner Change0%
Ins Owners16.62%
Ins Owner ChangeN/A
Market Cap304.06M
Analysts85.71
Price Target0.11 (-99.31%)
Short Float %1.31%
Short Ratio3.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)36.24%
Min EPS beat(2)-22.64%
Max EPS beat(2)95.12%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.21%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)-0.08%
Revenue beat(4)2
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.15%
Revenue beat(8)5
Avg Revenue beat(8)0.76%
Revenue beat(12)6
Avg Revenue beat(12)-18.08%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.72%
PT rev (3m)33.37%
EPS NQ rev (1m)-27.15%
EPS NQ rev (3m)-22.66%
EPS NY rev (1m)-27.15%
EPS NY rev (3m)-12.41%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)-2.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.84 | ||
| Fwd PE | 10.61 | ||
| P/S | 6.6 | ||
| P/FCF | 16.24 | ||
| P/OCF | 13.13 | ||
| P/B | 4.46 | ||
| P/tB | 4.46 | ||
| EV/EBITDA | 58.46 |
EPS(TTM)1.01
EY6.31%
EPS(NY)1.51
Fwd EY9.42%
FCF(TTM)0.99
FCFY6.16%
OCF(TTM)1.22
OCFY7.62%
SpS2.43
BVpS3.59
TBVpS3.59
PEG (NY)0.27
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.79% | ||
| ROE | 7.84% | ||
| ROCE | 2.17% | ||
| ROIC | 1.83% | ||
| ROICexc | 19.56% | ||
| ROICexgc | 19.56% | ||
| OM | 4.05% | ||
| PM (TTM) | 11.6% | ||
| GM | 74.52% | ||
| FCFM | 40.64% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score4
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.33 | ||
| Debt/EBITDA | 1.37 | ||
| Cap/Depr | 229.33% | ||
| Cap/Sales | 9.62% | ||
| Interest Coverage | 11.81 | ||
| Cash Conversion | 609.66% | ||
| Profit Quality | 350.45% | ||
| Current Ratio | 3.51 | ||
| Quick Ratio | 3.34 | ||
| Altman-Z | 4.25 |
F-Score4
WACC8.74%
ROIC/WACC0.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1178.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%141.89%
EPS Next Y58.83%
EPS Next 2Y54.54%
EPS Next 3Y53.27%
EPS Next 5YN/A
Revenue 1Y (TTM)26.5%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%21.26%
Revenue Next Year15%
Revenue Next 2Y18.5%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
EBIT growth 1Y155.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.13%
EBIT Next 3Y41.44%
EBIT Next 5YN/A
FCF growth 1Y321.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y429.93%
OCF growth 3Y127.03%
OCF growth 5YN/A